{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-26-000068","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.384391+00:00","generated_at":"2026-05-15T00:17:47.759407+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioRestorative Therapies approves 2025 executive bonuses; CEO bonus $300K, VP $287.5K, CFO $140K","bullets":["CEO Lance Alstodt awarded $300K cash bonus and $1.5M in option awards; total 2025 compensation $2.4M.","VP Francisco Silva gets $287.5K bonus plus $1.47M in options; total 2025 comp $2.3M.","CFO Robert Kristal awarded $140K bonus and $318K in options; total 2025 comp $801,750.","All bonuses are discretionary for 2025 services, payable in 2026; total compensation up significantly from 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-26-000068","json":"https://secwatch.observer/filing/0001021771-26-000068.json","markdown":"https://secwatch.observer/filing/0001021771-26-000068.md","text":"https://secwatch.observer/filing/0001021771-26-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000068/0001021771-26-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000068/brtx-20260501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:17:47.759407+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}